Marc DERIVE

En résumé

Entreprises

• INSERM - PostDoc

  PARIS 13 2011 - maintenant Immunotherapy of sepsis (Groupe CHOC, Equipe AVENIR Inserm)
  http://www.ncbi.nlm.nih.gov/pubmed?term=derive%20m[Author]

• INSERM - PhD

  PARIS 13 2007 - 2011 Immunotherapy of sepsis (Groupe CHOC, Equipe AVENIR Inserm)

Formations

• HEC (MBA equivalent)

  Jouy En Josas 2012 - 2013 Challenge Plus
  
  INOTREM Project
  INOTREM is a biopharmaceutic company that develops novel immunomodulators in areas of major unmet medical needs with a focus on critical care.

• Incubateur Lorrain

  Nancy 2011 - 2012 Projet INOTREM

• Ecole Biologie Industrielle Cergy

  Cergy Pontoise 2004 - 2005 MBE Master of Business and Engineering

Réseau

• Kévin PATRON

• Marjorie FOUGERE

• Stéphanie ALVES MIRANDA (AUBRY)

• Theophile DEJARDIN